Literature DB >> 25916268

Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.

Dania A Shah1, Raouf A Khalil2.   

Abstract

Preeclampsia is a pregnancy-associated disorder characterized by hypertension, and could lead to maternal and fetal morbidity and mortality; however, the pathophysiological mechanisms involved are unclear. Predisposing demographic, genetic and environmental risk factors could cause localized abnormalities in uteroplacental cytoactive factors such as integrins, matrix metalloproteinases, cytokines and major histocompatibility complex molecules leading to decreased vascular remodeling, uteroplacental vasoconstriction, trophoblast cells apoptosis, and abnormal development of the placenta. Defective placentation and decreased trophoblast invasion of the myometrium cause reduction in uteroplacental perfusion pressure (RUPP) and placental ischemia/hypoxia, an important event in preeclampsia. RUPP could stimulate the release of circulating bioactive factors such as the anti-angiogenic factors soluble fms-like tyrosine kinase-1 and soluble endoglin that cause imbalance with the pro-angiogenic factors vascular endothelial growth factor and placental growth factor, or cause the release of inflammatory cytokines, reactive oxygen species, hypoxia-induced factor-1 and AT1 angiotensin receptor agonistic autoantibodies. The circulating bioactive factors target endothelial cells causing generalized endotheliosis, endothelial dysfunction, decreased vasodilators such as nitric oxide and prostacyclin and increased vasoconstrictors such as endothelin-1 and thromboxane A2, leading to increased vasoconstriction. The bioactive factors also stimulate the mechanisms of VSM contraction including Ca(2+), protein kinase C, and Rho-kinase and induce extracellular matrix remodeling leading to further vasoconstriction and hypertension. While therapeutic options are currently limited, understanding the underlying mechanisms could help design new interventions for management of preeclampsia.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endothelium; Extracellular matrix; Hypertension; Preeclampsia; Pregnancy; Vascular smooth muscle

Mesh:

Substances:

Year:  2015        PMID: 25916268      PMCID: PMC4449835          DOI: 10.1016/j.bcp.2015.04.012

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  222 in total

Review 1.  Invasive cytotrophoblast apoptosis in pre-eclampsia.

Authors:  O Genbacev; E DiFederico; M McMaster; S J Fisher
Journal:  Hum Reprod       Date:  1999-12       Impact factor: 6.918

2.  The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia.

Authors:  Israel Hendler; Sean C Blackwell; Shobha H Mehta; Janice E Whitty; Evelyne Russell; Yoram Sorokin; David B Cotton
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

3.  Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.

Authors:  Michael L LeFevre
Journal:  Ann Intern Med       Date:  2014-12-02       Impact factor: 25.391

4.  Insulin resistance and preeclampsia in gestational diabetes mellitus.

Authors:  Martin N Montoro; Siri L Kjos; Mary Chandler; Ruth K Peters; Anny H Xiang; Thomas A Buchanan
Journal:  Diabetes Care       Date:  2005-08       Impact factor: 19.112

5.  Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: effect of magnesium sulfate.

Authors:  Alaa Amash; Gershon Holcberg; Olga Sapir; Mahmoud Huleihel
Journal:  J Interferon Cytokine Res       Date:  2012-08-21       Impact factor: 2.607

6.  Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction.

Authors:  Hong-wa Yung; Stefania Calabrese; Debby Hynx; Brian A Hemmings; Irene Cetin; D Stephen Charnock-Jones; Graham J Burton
Journal:  Am J Pathol       Date:  2008-06-26       Impact factor: 4.307

7.  L-arginine-nitric oxide pathway and oxidative stress in plasma and platelets of patients with pre-eclampsia.

Authors:  Adriana M L Pimentel; Natália R Pereira; Cristiane A Costa; Giovanni E Mann; Viviane S C Cordeiro; Roberto S de Moura; Tatiana M C Brunini; Antônio Cláudio Mendes-Ribeiro; Angela C Resende
Journal:  Hypertens Res       Date:  2013-04-11       Impact factor: 3.872

8.  Maternal and neonatal outcomes in pregnancies complicated by gestational diabetes. a nation-wide study.

Authors:  Per Glud Ovesen; Dorte Møller Jensen; Peter Damm; Steen Rasmussen; Ulrik Schiøler Kesmodel
Journal:  J Matern Fetal Neonatal Med       Date:  2015-01-08

9.  Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997-2008.

Authors:  Reeta Lamminpää; Katri Vehviläinen-Julkunen; Mika Gissler; Seppo Heinonen
Journal:  BMC Pregnancy Childbirth       Date:  2012-06-11       Impact factor: 3.007

10.  Therapeutic Potential of the Nitrite-Generated NO Pathway in Vascular Dysfunction.

Authors:  Michael Madigan; Brian Zuckerbraun
Journal:  Front Immunol       Date:  2013-07-02       Impact factor: 7.561

View more
  52 in total

Review 1.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

2.  Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.

Authors:  Juanjuan Chen; Zongli Ren; Minglin Zhu; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2017-05-12       Impact factor: 5.858

Review 3.  Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.

Authors:  Juanjuan Chen; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-22       Impact factor: 3.622

4.  Impairment of BKca channels in human placental chorionic plate arteries is potentially relevant to the development of preeclampsia.

Authors:  Mengzhou He; Fanfan Li; Meitao Yang; Yao Fan; Rajluxmee Beejadhursing; Yin Xie; Yuan Zhou; Dongrui Deng
Journal:  Hypertens Res       Date:  2017-11-16       Impact factor: 3.872

5.  Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-α.

Authors:  Wei Li; Ning Cui; Marc Q Mazzuca; Karina M Mata; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

6.  Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.

Authors:  Carlos A Dias-Junior; Juanjuan Chen; Ning Cui; Charles L Chiang; Minglin Zhu; Zongli Ren; Jose S Possomato-Vieira; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2017-09-11       Impact factor: 5.858

Review 7.  Comparative risks and predictors of preeclamptic pregnancy in the Eastern, Western and developing world.

Authors:  Ning Zhang; Jing Tan; HaiFeng Yang; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2020-09-25       Impact factor: 5.858

8.  Placental hypoxia-induced alterations in vascular function, morphology, and endothelial barrier integrity.

Authors:  Philippe Vangrieken; Alex H V Remels; Salwan Al-Nasiry; Aalt Bast; Ger M J Janssen; Ulrike von Rango; Daan Vroomans; Yannick C W Pinckers; Frederik J van Schooten; Paul M H Schiffers
Journal:  Hypertens Res       Date:  2020-07-30       Impact factor: 3.872

9.  AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats.

Authors:  Mark W Cunningham; Javier Castillo; Tarek Ibrahim; Denise C Cornelius; Nathan Campbell; Lorena Amaral; Venkata Ramana Vaka; Nathan Usry; Jan M Williams; Babbette LaMarca
Journal:  Hypertension       Date:  2018-03-19       Impact factor: 10.190

10.  Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.

Authors:  J S Possomato-Vieira; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.